Trials / Unknown
UnknownNCT01245075
Deep Brain Stimulation of the Nucleus Accumbens as a Novel Treatment in Severe Opioid Addiction
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Jens Kuhn · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to assess the efficacy of bilateral deep brain stimulation (DBS) of the Nucleus accumbens (NAc) as a novel treatment in severe opioid addiction. The included patients have been treated so far with a substitute in form of methadone. Our hypothesis is that bilateral DBS of the NAc will significantly reduce the craving for heroin and thus enable the patients to decrease their Levomethadone-dosage substantially.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Deep brain stimulation | Deep brain stimulation on |
| OTHER | Placebo | deep brain stimulation off |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2017-06-01
- Completion
- 2017-12-01
- First posted
- 2010-11-22
- Last updated
- 2016-12-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01245075. Inclusion in this directory is not an endorsement.